AllianceBernstein
ELDN icon

AllianceBernstein’s Eledon Pharmaceuticals ELDN Stock Holding History

AllianceBernstein’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.8K Buy
+32,400
New +$118K ﹤0.01% 3258
2015
Q3 		– Sell
-285
Closed -$613K – 2958
2015
Q2 		$613K Buy
285
+276
+3,067% +$534K ﹤0.01% 2521
2015
Q1 		$16K Buy
+9
New +$19.9K ﹤0.01% 3296

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

AllianceBernstein's ELDN Position: Q2 2026 in Review

AllianceBernstein opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 32,400 shares worth $99.8K. The stake represents ﹤0.01% of the portfolio and ranks #3258 among its holdings. This is a return to the name: AllianceBernstein previously reported a position in ELDN as recently as Q2 2015.

AllianceBernstein first reported a position in ELDN in Q1 2015 and has held it in 3 quarters since. The position peaked at $613K in Q2 2015. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • AllianceBernstein held 32,400 shares of Eledon Pharmaceuticals worth $99.8K as of Q2 2026.
  • Eledon Pharmaceuticals was a new AllianceBernstein position in Q2 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3258 holding.
  • AllianceBernstein first reported a position in Eledon Pharmaceuticals in Q1 2015 and has held it in 3 quarters since.
  • AllianceBernstein's Eledon Pharmaceuticals position peaked at $613K in Q2 2015.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.